BRIEF—UMCG and SHINE receive $11 million grant for cancer study

University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments.

The Terbium for Life project aims to reduce Europe's reliance on foreign isotope suppliers by establishing a stable European supply chain. Terbium isotopes will be used in cancer theranostics, which combine diagnosis and therapy in a single approach.

Terbium-161, one of the key isotopes in the project, shows promise in improving patient outcomes by extending lifespans and minimizing side effects. The project also explores other isotopes, including Tb-149, Tb-155, and Tb-152.

UMCG’s Philip Elsinga said: "This collaboration brings together unique expertise in nuclear medicine and radiotheranostics,” adding: “Our goal is to develop treatments offering new hope for cancer patients."